Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Data from Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth

View through CrossRef
<div>Abstract<p>The Wnt/β-catenin pathway regulates T-cell functions, including the repression of effector functions to the advantage of memory development via Tcf1. In a companion study, we demonstrate that, in human cancers, Wnt3a/β-catenin signaling maintains tumor-infiltrating T cells in a partially exhausted status. Here, we have investigated the effects of Wnt3a neutralization <i>in vivo</i> in a mouse tumor model. Abundant Wnt3a was released, mostly by stromal cells, in the tumor microenvironment. We tested whether Wnt3a neutralization <i>in vivo</i> could rescue the effector capacity of tumor-infiltrating T cells, by administering an antibody to Wnt3a to tumor-bearing mice. This therapy restrained tumor growth and favored the expansion of tumor antigen–specific CD8<sup>+</sup> effector memory T cells with increased expression of Tbet and IFNγ and reduced expression of Tcf1. However, the effect was not attributable to the interruption of T-cell–intrinsic β-catenin signaling, because Wnt3a/β-catenin activation correlated with enhanced, not reduced, T-cell effector functions both <i>ex vivo</i> and <i>in vitro</i>. Adoptively transferred CD8<sup>+</sup> T cells, not directly exposed to the anti-Wnt3a antibody but infiltrating previously Wnt3a-neutralized tumors, also showed improved functions. The rescue of T-cell response was thus secondary to T-cell–extrinsic changes that likely involved dendritic cells. Indeed, tumor-derived Wnt3a strongly suppressed dendritic cell maturation <i>in vitro</i>, and anti-Wnt3a treatment rescued dendritic cell activities <i>in vivo</i>. Our results clarify the function of the Wnt3a/β-catenin pathway in antitumor effector T cells and suggest that Wnt3a neutralization might be a promising immunotherapy for rescuing dendritic cell activities. <i>Cancer Immunol Res; 6(8); 953–64. ©2018 AACR</i>.</p></div>
Title: Data from Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth
Description:
<div>Abstract<p>The Wnt/β-catenin pathway regulates T-cell functions, including the repression of effector functions to the advantage of memory development via Tcf1.
In a companion study, we demonstrate that, in human cancers, Wnt3a/β-catenin signaling maintains tumor-infiltrating T cells in a partially exhausted status.
Here, we have investigated the effects of Wnt3a neutralization <i>in vivo</i> in a mouse tumor model.
Abundant Wnt3a was released, mostly by stromal cells, in the tumor microenvironment.
We tested whether Wnt3a neutralization <i>in vivo</i> could rescue the effector capacity of tumor-infiltrating T cells, by administering an antibody to Wnt3a to tumor-bearing mice.
This therapy restrained tumor growth and favored the expansion of tumor antigen–specific CD8<sup>+</sup> effector memory T cells with increased expression of Tbet and IFNγ and reduced expression of Tcf1.
However, the effect was not attributable to the interruption of T-cell–intrinsic β-catenin signaling, because Wnt3a/β-catenin activation correlated with enhanced, not reduced, T-cell effector functions both <i>ex vivo</i> and <i>in vitro</i>.
Adoptively transferred CD8<sup>+</sup> T cells, not directly exposed to the anti-Wnt3a antibody but infiltrating previously Wnt3a-neutralized tumors, also showed improved functions.
The rescue of T-cell response was thus secondary to T-cell–extrinsic changes that likely involved dendritic cells.
Indeed, tumor-derived Wnt3a strongly suppressed dendritic cell maturation <i>in vitro</i>, and anti-Wnt3a treatment rescued dendritic cell activities <i>in vivo</i>.
Our results clarify the function of the Wnt3a/β-catenin pathway in antitumor effector T cells and suggest that Wnt3a neutralization might be a promising immunotherapy for rescuing dendritic cell activities.
<i>Cancer Immunol Res; 6(8); 953–64.
©2018 AACR</i>.
</p></div>.

Related Results

Wnt5a Inhibits Wnt3a-Mediated HSC Differentiation.
Wnt5a Inhibits Wnt3a-Mediated HSC Differentiation.
Abstract Activation of the canonical Wnt signaling pathway by Wnt3a has been implicated in hematopoietic stem cell (HSC) self-renewal (Reya et al., Nature, 2003). Wn...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Data from Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth
Data from Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth
<div>Abstract<p>The Wnt/β-catenin pathway regulates T-cell functions, including the repression of effector functions to the advantage of memory development via Tcf1. In...
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
Macroeconomic and Social Precursors of Suicide Rates in the Philippines: A Quantitative Analysis (Preprint)
BACKGROUND Suicide is a complex, serious and multifaceted public health issue that poses significant challenges to societies worldwide. In fact, it represen...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
PGE2 and WNT3a Promote Skeletal Muscle Regeneration after Barium Chloride Damage In‐vitro
PGE2 and WNT3a Promote Skeletal Muscle Regeneration after Barium Chloride Damage In‐vitro
IntroductionAlthough skeletal muscle has a remarkable regenerative capacity, certain traumatic injuries are beyond the normal physiologic repair and require extensive regenerative ...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...

Back to Top